Another common factor is the elevated levels of AD biomarkers such as amyloid β and/or tau protein in blood and cerebrospinal fluid (CSF) observable in OSA patients, which are frequently correlated with hypoxia severity [118,119,120,121,122]. Here, MAPT is linked to obstructive sleep apnea syndrome.